arsenic has been researched along with dibromobimane in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, YF; Rosen, BP; Yang, J | 1 |
| Andreu, D; Bray, F; de la Torre, BG; Díez-Dacal, B; García de Lacoba, M; García-Domínguez, CA; Oeste, CL; Pérez-Inestrosa, E; Pérez-Sala, D; Rojas, JM; Ruiz-Sánchez, AJ | 1 |
| Algieri, C; Nesci, S; Pagliarani, A; Trombetti, F; Ventrella, V | 1 |
3 other study(ies) available for arsenic and dibromobimane
| Article | Year |
|---|---|
ArsD residues Cys12, Cys13, and Cys18 form an As(III)-binding site required for arsenic metallochaperone activity.
Topics: Amino Acid Sequence; Arsenic; Bacterial Proteins; Binding Sites; Biological Transport; Bridged Bicyclo Compounds; Cysteine; Escherichia coli; Molecular Chaperones; Molecular Sequence Data; Sequence Homology, Amino Acid; Trans-Activators; Two-Hybrid System Techniques | 2007 |
The C-terminus of H-Ras as a target for the covalent binding of reactive compounds modulating Ras-dependent pathways.
Topics: Animals; Arsenicals; Binding Sites; Bridged Bicyclo Compounds; Cell Line; Cross-Linking Reagents; Cyclopentanes; Cysteine; Enzyme Inhibitors; Humans; Prostaglandins; Protein Binding; Protein Processing, Post-Translational; Proto-Oncogene Proteins p21(ras); ras Proteins; Signal Transduction; Transfection | 2011 |
The mitochondrial F
Topics: Animals; Arsenicals; Bridged Bicyclo Compounds; Calcium; Cysteine; Dithioerythritol; Enzyme Activators; Enzyme Inhibitors; Magnesium; Mitochondria; Mitochondrial Permeability Transition Pore; Oxidation-Reduction; Oxidative Stress; Proton-Translocating ATPases; Swine | 2021 |